Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company developing innovative targeted biologic ...

Hypoalbuminemia is a blood albumin level of less than 3.5 grams per deciliter (g/dL). It often occurs as a result of a serious underlying medical condition, such as kidney, liver, or heart failure.

Medicenna is a Canadian biotech company developing Superkines, enhanced cytokine drugs, in oncology. Read more about MDNAF stock here.

This story is part of a series, “Fighting ‘Forever Chemicals’: Women face pervasive PFAS risks.” Cancer-linked “forever ...

In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria -; albumin in urine, a sign of kidney damage -; for 50% of participants.

A recent study published in the recent edition of Nature Scientific Reports highlight on a critical aspect of managing ...

The A/G ratio is a test that measures the amount of proteins called albumin and globulin in your blood. The A/G ratio may be ...

Since data were collected from only 23 pediatric patients receiving albumin, these results are presented separately. Of the 1649 adult patients, 904 (54.8%) were given albumin in an intensive care ...

Allied Market Research published a report, titled, “Albumin Market by Type (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), Application (Therapeutics, Drug Formulation & Vaccines, ...

Distribution of EUR 0.04 per preference share for each of the years 2023 and 2022 Broad majority in the vote in line with the management's proposalsDREIEICH, Germany - (NewMediaWire) - May 7, 2024 - ...

Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. Biotest has more than 2 ...